Aging may be driven by enzymes leaking from our intestines, breaking down tissue and contributing to insulin resistance. Can stopping them slow the aging
NLRC5 drives inflammatory cell death in diseases like colitis. Targeting NAD+ or inhibiting NLRC5 could offer promising treatments, reducing inflammation.